14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $43.33 $53.35 Thursday, 2nd May 2024 BMY stock ended at $43.70. This is 1.15% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.51% from a day low at $43.33 to a day high of $44.42.
90 days $43.33 $55.03
52 weeks $43.33 $69.10

Historical Bristol-Myers Squibb Company prices

Date Open High Low Close Volume
Mar 27, 2024 $53.00 $53.69 $52.85 $53.25 12 223 919
Mar 26, 2024 $52.39 $52.65 $52.04 $52.55 9 529 830
Mar 25, 2024 $52.08 $52.74 $51.92 $52.25 8 793 294
Mar 22, 2024 $51.65 $52.45 $51.52 $51.93 7 928 249
Mar 21, 2024 $51.91 $52.65 $51.56 $51.59 12 558 770
Mar 20, 2024 $51.63 $52.16 $51.27 $51.88 6 529 098
Mar 19, 2024 $51.76 $51.93 $51.39 $51.80 14 541 407
Mar 18, 2024 $52.58 $52.70 $51.54 $51.59 11 798 980
Mar 15, 2024 $52.32 $53.20 $51.95 $52.34 19 286 574
Mar 14, 2024 $52.57 $52.68 $51.81 $52.49 14 351 801
Mar 13, 2024 $54.33 $55.03 $52.60 $52.65 18 470 813
Mar 12, 2024 $54.33 $54.60 $53.82 $54.40 10 309 440
Mar 11, 2024 $53.90 $54.56 $53.74 $54.36 13 763 948
Mar 08, 2024 $53.48 $54.26 $53.33 $53.79 16 908 064
Mar 07, 2024 $53.57 $53.75 $52.98 $53.28 13 936 207
Mar 06, 2024 $52.34 $53.81 $52.25 $53.38 21 211 652
Mar 05, 2024 $51.01 $52.11 $50.99 $51.82 12 607 076
Mar 04, 2024 $51.28 $52.20 $50.72 $50.92 16 798 882
Mar 01, 2024 $50.94 $51.08 $50.44 $50.89 10 795 063
Feb 29, 2024 $50.96 $51.17 $50.28 $50.75 14 568 434
Feb 28, 2024 $50.51 $50.97 $50.38 $50.92 6 418 734
Feb 27, 2024 $50.57 $50.72 $50.15 $50.51 6 616 586
Feb 26, 2024 $51.56 $51.68 $50.47 $50.52 7 837 748
Feb 23, 2024 $51.40 $51.92 $50.73 $51.66 11 041 794
Feb 22, 2024 $50.58 $51.41 $50.34 $51.33 10 425 602
Click to get the best stock tips daily for free!

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th... BMY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT